BI

BVF Inc Portfolio holdings

AUM $2.8B
This Quarter Return
-17.58%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$495M
AUM Growth
+$495M
Cap. Flow
+$20.2M
Cap. Flow %
4.08%
Top 10 Hldgs %
75.58%
Holding
34
New
4
Increased
10
Reduced
5
Closed
7

Top Buys

1
IRWD icon
Ironwood Pharmaceuticals
IRWD
$28.2M
2
CASC
Cascadian Therapeutics, Inc.
CASC
$18.1M
3
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
$14.6M
4
VTAE
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
$8.49M
5
XENE icon
Xenon Pharmaceuticals
XENE
$2.95M

Top Sells

1
GYRE icon
Gyre Therapeutics
GYRE
$26.3M
2
EXEL icon
Exelixis
EXEL
$10.4M
3
SGEN
Seagen Inc. Common Stock
SGEN
$9.68M
4
FPRX
Five Prime Therapeutics, Inc.
FPRX
$5.98M
5
CNCE
Concert Pharmaceuticals, Inc.
CNCE
$5M

Sector Composition

1 Healthcare 62%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
IRWD icon
1
Ironwood Pharmaceuticals
IRWD
$214M
$50.8M 10.26% 4,874,373 +2,703,265 +125% +$28.2M
CCXI
2
DELISTED
ChemoCentryx, Inc.
CCXI
$45.8M 9.26% 7,573,493 +303,480 +4% +$1.84M
CASC
3
DELISTED
Cascadian Therapeutics, Inc.
CASC
$44.8M 9.06% 16,360,538 +6,606,360 +68% +$18.1M
ARRY
4
DELISTED
Array Biopharma Inc
ARRY
$44.1M 8.92% 9,680,630 +511,354 +6% +$2.33M
CNCE
5
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$42.3M 8.55% 2,255,168 -266,284 -11% -$5M
BPMC
6
DELISTED
Blueprint Medicines
BPMC
$36.3M 7.34% 1,702,654 +120,246 +8% +$2.57M
LOXO
7
DELISTED
Loxo Oncology, Inc
LOXO
$26.8M 5.41% 1,531,108 -83,973 -5% -$1.47M
VTAE
8
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
$26.2M 5.28% 2,375,933 +771,318 +48% +$8.49M
FWP
9
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
$23.9M 4.84% 1,016,324 +7,343 +0.7% +$173K
OMED
10
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$22.8M 4.61% 1,376,113 +111,398 +9% +$1.85M
CTIC
11
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$14.6M 2.95% +10,000,000 New +$14.6M
CYTK icon
12
Cytokinetics
CYTK
$4.23B
$14.1M 2.85% 2,106,989 – –
ARQL
13
DELISTED
Arqule Inc
ARQL
$12.3M 2.48% 6,566,148 +135,440 +2% +$253K
TBRA
14
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
$11.4M 2.29% 1,175,233 – –
QLTI
15
DELISTED
QLT Inc
QLTI
$9.94M 2.01% 3,737,446 – –
XENE icon
16
Xenon Pharmaceuticals
XENE
$2.98B
$8.55M 1.73% 1,035,572 +356,808 +53% +$2.95M
ONCT
17
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$8.19M 1.65% 10,772,306 – –
GYRE icon
18
Gyre Therapeutics
GYRE
$703M
$4.76M 0.96% 1,020,874 -5,634,254 -85% -$26.3M
SVRA icon
19
Savara
SVRA
$567M
$2.96M 0.6% 5,104,068 -7,225 -0.1% -$4.19K
CALA
20
DELISTED
Calithera Biosciences, Inc
CALA
$2.48M 0.5% +456,500 New +$2.48M
VIRX
21
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$2.03M 0.41% +2,500,000 New +$2.03M
GBIM
22
DELISTED
GLOBEIMMUNE INC COM STK (DE)
GBIM
$1.77M 0.36% 678,400 – –
SAVA icon
23
Cassava Sciences
SAVA
$110M
$1.7M 0.34% +928,760 New +$1.7M
VXRT
24
DELISTED
Vaxart
VXRT
$695K 0.14% 350,776 – –
APTO
25
DELISTED
Aptose Biosciences, Inc.
APTO
$179K 0.04% 41,600 -63,829 -61% -$275K
1
2